187 related articles for article (PubMed ID: 35335892)
1. Creating Acceptable Tablets 3D (CAT 3D): A Feasibility Study to Evaluate the Acceptability of 3D Printed Tablets in Children and Young People.
Bracken L; Habashy R; McDonough E; Wilson F; Shakeshaft J; Ohia U; Garcia-Sorribes T; Isreb A; Alhnan MA; Peak M
Pharmaceutics; 2022 Feb; 14(3):. PubMed ID: 35335892
[TBL] [Abstract][Full Text] [Related]
2. Can children swallow tablets? Outcome data from a feasibility study to assess the acceptability of different-sized placebo tablets in children (creating acceptable tablets (CAT)).
Bracken L; McDonough E; Ashleigh S; Wilson F; Shakeshaft J; Ohia U; Mistry P; Jones H; Kanji N; Liu F; Peak M
BMJ Open; 2020 Oct; 10(10):e036508. PubMed ID: 33039988
[TBL] [Abstract][Full Text] [Related]
3. Influence of the geometry of 3D printed solid oral dosage forms on their swallowability.
Bogdahn M; Torner J; Krause J; Grimm M; Weitschies W
Eur J Pharm Biopharm; 2021 Oct; 167():65-72. PubMed ID: 34298113
[TBL] [Abstract][Full Text] [Related]
4. I Spy with My Little Eye: A Paediatric Visual Preferences Survey of 3D Printed Tablets.
Januskaite P; Xu X; Ranmal SR; Gaisford S; Basit AW; Tuleu C; Goyanes A
Pharmaceutics; 2020 Nov; 12(11):. PubMed ID: 33212847
[TBL] [Abstract][Full Text] [Related]
5. Development of immediate release 3D-printed dosage forms for a poorly water-soluble drug by fused deposition modeling: Study of morphology, solid state and dissolution.
Fanous M; Bitar M; Gold S; Sobczuk A; Hirsch S; Ogorka J; Imanidis G
Int J Pharm; 2021 Apr; 599():120417. PubMed ID: 33647418
[TBL] [Abstract][Full Text] [Related]
6. Patient acceptability of 3D printed medicines.
Goyanes A; Scarpa M; Kamlow M; Gaisford S; Basit AW; Orlu M
Int J Pharm; 2017 Sep; 530(1-2):71-78. PubMed ID: 28750894
[TBL] [Abstract][Full Text] [Related]
7. Patient Acceptability and Preferences for Solid Oral Dosage Form Drug Product Attributes: A Scoping Review.
Hauber B; Hand MV; Hancock BC; Zarrella J; Harding L; Ogden-Barker M; Antipas AS; Watt SJ
Patient Prefer Adherence; 2024; 18():1281-1297. PubMed ID: 38919378
[TBL] [Abstract][Full Text] [Related]
8. Multi-Analytical Framework to Assess the In Vitro Swallowability of Solid Oral Dosage Forms Targeting Patient Acceptability and Adherence.
Ershad AL; Rajabi-Siahboomi A; Missaghi S; Kirby D; Mohammed AR
Pharmaceutics; 2021 Mar; 13(3):. PubMed ID: 33808875
[TBL] [Abstract][Full Text] [Related]
9. Evaluating the Acceptability, Swallowability, and Palatability of Film-Coated Mini-Tablet Formulation in Young Children: Results from an Open-Label, Single-Dose, Cross-Over Study.
Münch J; Sessler I; Bosse HM; Wargenau M; Dreesen JD; Loforese G; Webb NJA; Sivasubramanian R; Reidemeister S; Lustenberger P; Klingmann V
Pharmaceutics; 2023 Jun; 15(6):. PubMed ID: 37376177
[TBL] [Abstract][Full Text] [Related]
10. Sensory aspects of acceptability of bitter-flavoured 7.5 mm film-coated tablets in adults, preschool and school children.
Hofmanová JK; Mason J; Batchelor HK
Int J Pharm; 2020 Jul; 585():119511. PubMed ID: 32522503
[TBL] [Abstract][Full Text] [Related]
11. 3D printing of pharmaceutical oral solid dosage forms by fused deposition: The enhancement of printability using plasticised HPMCAS.
Oladeji S; Mohylyuk V; Jones DS; Andrews GP
Int J Pharm; 2022 Mar; 616():121553. PubMed ID: 35131354
[TBL] [Abstract][Full Text] [Related]
12. Performance and paroxetine stability in tablets manufactured by fused deposition modelling-based 3D printing.
Figueiredo S; Fernandes AI; Carvalho FG; Pinto JF
J Pharm Pharmacol; 2022 Jan; 74(1):67-76. PubMed ID: 34591102
[TBL] [Abstract][Full Text] [Related]
13. Influence of Solid Oral Dosage Form Characteristics on Swallowability, Visual Perception, and Handling in Older Adults.
Hummler H; Page S; Stillhart C; Meilicke L; Grimm M; Mannaa M; Gollasch M; Weitschies W
Pharmaceutics; 2023 Apr; 15(4):. PubMed ID: 37111799
[TBL] [Abstract][Full Text] [Related]
14. Acceptability, Swallowability, Palatability, and Safety of Multiple Film-Coated Mini-Tablets in Children Aged ≥2-<7 Years: Results of an Open-Label Randomised Study.
Münch J; Kloft C; Farhan M; Fishman V; Leng S; Bosse HM; Klingmann V
Pharmaceutics; 2023 Feb; 15(2):. PubMed ID: 36840023
[TBL] [Abstract][Full Text] [Related]
15. Can filaments be stored as a shelf-item for on-demand manufacturing of oral 3D printed tablets? An initial stability assessment.
Okwuosa TC; Sadia M; Isreb A; Habashy R; Peak M; Alhnan MA
Int J Pharm; 2021 May; 600():120442. PubMed ID: 33675925
[TBL] [Abstract][Full Text] [Related]
16. Impact of Tablet Size and Shape on the Swallowability in Older Adults.
Hummler H; Stillhart C; Meilicke L; Grimm M; Krause E; Mannaa M; Gollasch M; Weitschies W; Page S
Pharmaceutics; 2023 Mar; 15(4):. PubMed ID: 37111528
[TBL] [Abstract][Full Text] [Related]
17. 3D printed extended release tablets for once daily use: An in vitro and in vivo evaluation study for a personalized solid dosage form.
Gültekin HE; Tort S; Tuğcu-Demiröz F; Acartürk F
Int J Pharm; 2021 Mar; 596():120222. PubMed ID: 33484916
[TBL] [Abstract][Full Text] [Related]
18. A Lower Temperature FDM 3D Printing for the Manufacture of Patient-Specific Immediate Release Tablets.
Okwuosa TC; Stefaniak D; Arafat B; Isreb A; Wan KW; Alhnan MA
Pharm Res; 2016 Nov; 33(11):2704-12. PubMed ID: 27506424
[TBL] [Abstract][Full Text] [Related]
19. Perceptions, preferences and acceptability of patient designed 3D printed medicine by polypharmacy patients: a pilot study.
Fastø MM; Genina N; Kaae S; Kälvemark Sporrong S
Int J Clin Pharm; 2019 Oct; 41(5):1290-1298. PubMed ID: 31444687
[TBL] [Abstract][Full Text] [Related]
20. Role of release modifiers to modulate drug release from fused deposition modelling (FDM) 3D printed tablets.
Shi K; Salvage JP; Maniruzzaman M; Nokhodchi A
Int J Pharm; 2021 Mar; 597():120315. PubMed ID: 33540000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
